FdaApplication
NDA 021223
Identifiers
- fda_app_no: NDA021223
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2001-08-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZOMETA | ZOLEDRONIC ACID | EQ 4MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
| ZOMETA | ZOLEDRONIC ACID | EQ 4MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
| ZOMETA | ZOLEDRONIC ACID | EQ 4MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
3 products